Literature DB >> 705769

HLA-A, -B, -C and -D antigens in male patients with myasthenia gravis.

J Säfwenberg, L Hammarström, J B Lindblom, G Matell, E Möller, P O Osterman, C I Smith.   

Abstract

HLA-A, -B, -C and -D antigens were determined in 54 male Myasthenia Gravis patients. A significant increase of the B8 antigen frequency was found among patients with an onset of the disease before the age of 35. No significant increase was found among the D antigens. In a combined male and female material with an early age at onset, thymic hyperplasia was correlated to the presence of HLA-B8.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 705769     DOI: 10.1111/j.1399-0039.1978.tb01309.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  8 in total

1.  Ek alpha transgene in B10 mice suppresses the development of myasthenia gravis.

Authors:  P Christadoss; C S David; M Shenoy; S Keve
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

2.  In vivo therapy with monoclonal anti-I-A antibody suppresses immune responses to acetylcholine receptor.

Authors:  M K Waldor; S Sriram; H O McDevitt; L Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

3.  Immune disease and HLA associations with myasthenia gravis.

Authors:  P O Behan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-07       Impact factor: 10.154

4.  HLA antigens and myasthenia gravis in north India.

Authors:  N K Mehra; G K Ahuja; V Taneja; M C Vaidya
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-04       Impact factor: 10.154

5.  In vivo effects of antibodies to immune response gene products: prevention of experimental allergic encephalitis.

Authors:  L Steinman; J T Rosenbaum; S Sriram; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

6.  Myasthenia gravis: overlap with 'polyendocrine' autoimmunity.

Authors:  W A Scherbaum; F Schumm; B Maisch; C Müller; A Fateh-Moghadam; S H Flüchter; F J Seif; G F Bottazzo; P A Berg
Journal:  Klin Wochenschr       Date:  1983-05-16

7.  An approach to the localization of the susceptibility genes for generalized myasthenia gravis by mapping recombinant ancestral haplotypes.

Authors:  M A Degli-Esposti; A Andreas; F T Christiansen; B Schalke; E Albert; R L Dawkins
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

8.  Mutation at I-A beta chain prevents experimental autoimmune myasthenia gravis.

Authors:  P Christadoss; J M Lindstrom; R W Melvold; N Talal
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.